The case for AI precharting in US primary care is already proven. The AAFP validated Navina's AI assistant and found a 61% reduction in visit preparation time, physicians feeling fully prepared for 81% of visits (up from 54%), and a 25% increase in diagnoses identified. DeepScribe, Freed, and Abridge are all adding pre-visit preparation features.
UK general practice arguably needs precharting more than the US does. And yet, no UK-specific precharting tool exists.
Why the Need Is Greater
Ten-minute consultations leave zero time for chart review. US primary care visits average 15-20 minutes. UK GP consultations are typically 10 minutes. There is no built-in time to review the patient's record. Most GPs glance at the last consultation, check recent results if they remember, and rely on the patient to fill in the gaps.
Locum and sessional coverage creates continuity gaps. UK general practice increasingly relies on locum GPs and physician associates who may not know the patient. A locum arriving at an unfamiliar practice with a full clinic list has no practical way to review each patient's history in advance. An AI pre-chart would transform the locum experience.
QOF coding is analogous to US HCC capture. The Quality and Outcomes Framework links practice income to clinical quality indicators. Many QOF points are missed because the opportunity was not visible during the consultation. An AI pre-chart surfacing QOF-relevant care gaps would directly improve revenue and care quality.
EMIS and SystmOne records accumulate decades of data. A GP record active for 30 years contains thousands of entries. Reviewing this manually is impossible in clinical time. AI summarisation is the only practical solution for complex records.
Multi-morbidity is endemic. The typical GP patient over 65 has three or more chronic conditions and five or more medications. Managing these safely requires knowing what every specialist has recommended and what investigations are outstanding.
Why No One Is Building It
EMIS and SystmOne APIs are more restrictive than Epic's. US precharting is built on deep Epic integration. EMIS and SystmOne have APIs but they are less open and less frequently used by third-party developers.
NHS procurement is slow. US health systems can pilot AI tools in weeks. NHS procurement involves DTAC, DPIAs, clinical safety cases, and multiple governance layers. Time from interest to deployment is measured in months.
The UK scribe market is still in early adoption. Heidi and TORTUS are gaining traction, but ambient scribing is still a novelty. Pre-charting is a step beyond scribing — and the market has not absorbed the current step.
Value-based incentives are weaker. US precharting adoption is partly driven by HCC revenue. QOF exists but the financial incentives are smaller.
What It Would Take
A UK GP precharting tool would need native EMIS/SystmOne integration, the ability to summarise structured and unstructured record data, QOF care gap identification, medication review and interaction flagging, and summary generation in a format reviewable in 60-90 seconds.
The clinical knowledge layer underneath would need NICE, CKS, SIGN, and BNF grounding. iatroX's Knowledge Centre already provides this. A UK precharting tool integrating with iatroX for guideline verification would have both the data summarisation and clinical evidence layers in place.
What Clinicians Can Do Now
Before complex appointments, spend 60 seconds on Ask iatroX checking the current guideline for the patient's main condition. For chronic disease reviews, use QOF indicators and clinical system alerts as a manual pre-chart. For locum shifts, ask the practice team for a brief list of complex patients with key issues highlighted.
These manual approximations are imperfect. But they demonstrate the value that a dedicated AI pre-charting tool would deliver at scale.
Conclusion
UK general practice needs AI precharting. The first vendor that builds a credible, EMIS/SystmOne-integrated, NICE-grounded pre-charting tool will define a category. Until then, clinicians should use iatroX for guideline retrieval, clinical system alerts for care gaps, and manual preparation for the patients who need it most.